An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial

M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Bleeding rates on dual antiplatelet therapy (DAPT) within 1 month after
percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in …
被引用次数：22 相关文章

An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial

M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - 2024 - pubmed.ncbi.nlm.nih.gov
Background Bleeding rates on dual antiplatelet therapy (DAPT) within 1 month after
percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in …

An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial

M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - Circulation, 2024 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> BACKGROUND:</jats: title>< jats: p> Bleeding rates on dual
antiplatelet therapy (DAPT) within 1 month after percutaneous coronary intervention (PCI) …
[PDF] archive.org

[PDF][PDF] An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial

M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - Circulation, 2023 - scholar.archive.org
BACKGROUND: Bleeding rates on dual antiplatelet therapy (DAPT) within 1 month after
percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in …

An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial

M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Bleeding rates on dual antiplatelet therapy (DAPT) within 1 month after
percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in …

An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.

M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - Circulation, 2023 - europepmc.org
Background Bleeding rates on dual antiplatelet therapy (DAPT) within 1 month after
percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in …